Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |